• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性多巴胺激动剂N-0437的口服活性氨基甲酸酯前药:6-羟基多巴胺旋转模型中的体内活性和体外活性

Orally active carbamate prodrugs of the selective dopamine agonist N-0437: in-vivo activities in the 6-OHDA turning model and in-vitro activities.

作者信息

den Daas I, de Boer P, Tepper P G, Rollema H, Horn A S

机构信息

Department of Medicinal Chemistry, University Centre for Pharmacy, Groningen, The Netherlands.

出版信息

J Pharm Pharmacol. 1991 Jan;43(1):11-6. doi: 10.1111/j.2042-7158.1991.tb05439.x.

DOI:10.1111/j.2042-7158.1991.tb05439.x
PMID:1676052
Abstract

The in-vivo activities of eight carbamate prodrugs of the D2-agonist N-0437 were determined by examining the effects of the prodrugs, after their oral administration in rats with unilateral 6-OHDA lesions of the striatum. The resulting contralateral turning was used as an index of the activity of the compounds. A comparison of the area under the curve of the time-effect curves of the prodrugs, revealed a significantly improved duration of action compared with N-0437 during the period 11-15 h after administration, for the propylcarbamate and the dimethoxyphenylcarbamate derivatives. The 2,4-dimethylphenylcarbamate showed a significantly enhanced turning behaviour over the whole 15 h time interval in comparison with N-0437. Three of the nine carbamates were virtually unhydrolysed in rat serum at 37 degrees C, while the other test compounds were hydrolysed relatively slowly, with t1/2 values ranging from 1.5-6 h. The test compounds differed greatly in partition coefficients, which were estimated by RP-HPLC (1-12 times more lipophilic than N-0437). The potential cholinesterase inhibiting properties of the carbamate prodrugs were assessed by a simple in-vitro incubation assay, which showed that only two carbamates were very weak cholinesterase inhibitors.

摘要

通过在单侧纹状体6-羟基多巴胺损伤的大鼠口服给药后,检测8种D2激动剂N-0437的氨基甲酸酯前药的体内活性。所产生的对侧旋转被用作化合物活性的指标。前药时间-效应曲线的曲线下面积比较显示,与N-0437相比,丙基氨基甲酸酯和二甲氧基苯基氨基甲酸酯衍生物在给药后11至15小时期间的作用持续时间显著改善。与N-0437相比,2,4-二甲基苯基氨基甲酸酯在整个15小时时间间隔内显示出显著增强的旋转行为。9种氨基甲酸酯中的3种在37℃的大鼠血清中几乎不被水解,而其他测试化合物水解相对较慢,t1/2值范围为1.5至6小时。测试化合物的分配系数差异很大,通过反相高效液相色谱法估计(比N-0437亲脂性高1至12倍)。通过简单的体外孵育试验评估氨基甲酸酯前药的潜在胆碱酯酶抑制特性,结果表明只有两种氨基甲酸酯是非常弱的胆碱酯酶抑制剂。

相似文献

1
Orally active carbamate prodrugs of the selective dopamine agonist N-0437: in-vivo activities in the 6-OHDA turning model and in-vitro activities.选择性多巴胺激动剂N-0437的口服活性氨基甲酸酯前药:6-羟基多巴胺旋转模型中的体内活性和体外活性
J Pharm Pharmacol. 1991 Jan;43(1):11-6. doi: 10.1111/j.2042-7158.1991.tb05439.x.
2
Improvement of the oral bioavailability of the selective dopamine agonist N-0437 in rats: the in vitro and in vivo activity of eight ester prodrugs.
Naunyn Schmiedebergs Arch Pharmacol. 1990 Mar;341(3):186-91. doi: 10.1007/BF00169729.
3
Transdermal administration of the dopamine agonist N-0437 and seven ester prodrugs: comparison with oral administration in the 6-OHDA turning model.
Naunyn Schmiedebergs Arch Pharmacol. 1990 Dec;342(6):655-9. doi: 10.1007/BF00175708.
4
Carbamate ester prodrugs of dopaminergic compounds: synthesis, stability, and bioconversion.多巴胺能化合物的氨基甲酸酯前药:合成、稳定性及生物转化
J Pharm Sci. 1991 Aug;80(8):793-8. doi: 10.1002/jps.2600800819.
5
Pharmacological profile of non-hydroxylated and ether derivatives of the potent D2-selective agonist N-0437.强效D2选择性激动剂N-0437的非羟基化和醚衍生物的药理学特性
Naunyn Schmiedebergs Arch Pharmacol. 1991 Feb;343(2):134-42. doi: 10.1007/BF00168600.
6
ABT-431: the diacetyl prodrug of A-86929, a potent and selective dopamine D1 receptor agonist: in vitro characterization and effects in animal models of Parkinson's disease.ABT-431:A-86929的二乙酰前药,一种强效且选择性的多巴胺D1受体激动剂:体外特性及在帕金森病动物模型中的作用
J Pharmacol Exp Ther. 1996 Jan;276(1):150-60.
7
In vivo dopamine agonist properties of rotigotine: Role of D1 and D2 receptors.罗替戈汀的体内多巴胺激动剂特性:D1和D2受体的作用。
Eur J Pharmacol. 2016 Oct 5;788:183-191. doi: 10.1016/j.ejphar.2016.06.035. Epub 2016 Jun 22.
8
N-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease.N-0923是一种选择性多巴胺D2受体激动剂,在帕金森病的大鼠和猴子模型中具有疗效。
Mov Disord. 1994 Mar;9(2):147-54. doi: 10.1002/mds.870090204.
9
A carbamate-based approach to primaquine prodrugs: antimalarial activity, chemical stability and enzymatic activation.基于氨基甲酸酯的伯氨喹前药:抗疟活性、化学稳定性和酶激活。
Bioorg Med Chem. 2012 Jan 15;20(2):886-92. doi: 10.1016/j.bmc.2011.11.059. Epub 2011 Dec 3.
10
Effects of locally applied D1 and D2 agonists on striatal neurons with 6-OHDA and pertussis toxin lesions.局部应用D1和D2激动剂对6-羟基多巴胺和百日咳毒素损伤的纹状体神经元的影响。
Brain Res. 1991 Nov 15;564(2):279-85. doi: 10.1016/0006-8993(91)91464-c.

引用本文的文献

1
Antiparkinson prodrugs.抗帕金森病前体药物。
Molecules. 2008 Jan 16;13(1):46-68. doi: 10.3390/molecules13010046.